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Background and Aims: Post‑operative sore throat (POST) is a common undesirable consequence
of tracheal intubation. Magnesium, an N‑methyl‑D‑aspartate receptor antagonist, has anti‑nociceptive
and anti‑inflammatory properties, and has been found to be useful in POST prevention in various
trials. We conducted this systematic review and meta‑analysis to study the efficacy of topical
magnesium in preventing POST in adult patients undergoing surgery under general anaesthesia
with single lumen tracheal tube. Methods: Comprehensive literature search was performed in
PubMed, Google Scholar, EMBASE, Scopus and the Cochrane central registers of controlled
trial databases through July, 2018 and data were pooled using fixed effect modelling followed
by random‑effect methods (after assessing heterogeneity with fixed modelling). The primary
outcome was the incidence of POST at 24 h after surgery/extubation. Comparative results were
deliberated as pooled mean difference for continuous variables and Mantel–Haenszel (MH)
odds ratio for dichotomous variables. Statistical analysis was done using Comprehensive
Meta‑Analysis‑Version 3 (Biostat Inc., USA). Results: Seven trials involving 726 study participants
were included in the final analysis. Incidence of POST at 24 hours was significantly lower in
magnesium group (26/363) in comparison to active and non‑active control group (89/363);
P = 0.00‑ RR 0.22 (95%CI = 0.12‑0.39, I2 = 0%). No significant adverse events were reported with the
use of topical magnesium. Conclusion: Prophylactic use of topical magnesium before the induction
of general anaesthesia seems to be an effective measure to decrease the incidence of POST.

Key words: Magnesium sulphate, meta-analysism, postoperative sore throat, systematic review,
topical

INTRODUCTION
Post‑operative sore throat (POST) is a common
undesirable consequence of tracheal intubation. The
prevalence of POST ranges from 21% to 65% after
tracheal intubation varying in accordance with the
mechanical trauma during intubation, tracheal tube
cuff pressure leading to mucosal erosion, mucosal
inflammation and dehydration.[1,2] In addition to a
negative impact on patient satisfaction and recovery,
POST increases the expenditure of health care.[3]
A number of non‑pharmacological methods as well
as pharmacological agents have been used to mitigate
520

the condition. Non‑pharmacological methods include
use of supraglottic airway device instead of tracheal
tube, smaller tubes, limiting cuff pressure and gentle
oropharyngeal suctioning.[4,5] Various pharmacological
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agents like lignocaine, steroids and ketamine have
been used with varying degree of success to reduce
the incidence as well as severity of POST.[6‑10]
Magnesium, an N‑methyl‑D‑aspartate receptor
antagonist found in central as well as peripheral nervous
system, has anti‑nociceptive and anti‑inflammatory
properties; therefore, it has been hypothesised to be
useful for POST prevention.[11] Prophylactic efficacy of
magnesium has been assessed by various randomised
controlled trials showing controversial results.[12‑19]
To our knowledge, however, no systematic review
has summarised the magnitude of their prophylactic
efficacy from the numerous randomised trials
published. Our group conducted this systematic
review and meta‑analysis of prospective randomised
trials to study the efficacy of topical magnesium in
preventing POST in adult patients undergoing surgery
under general anaesthesia with single lumen tracheal
tube.

METHODS
Cochrane collaboration methodology[20] and Preferred
Reporting Items for Systematic Reviews and
Meta‑Analyses PRISMA[21] statement were followed
for the conduct of our systematic meta‑analysis.
Following are the eligibility criteria.
Study type: Only randomised controlled trials were
considered for enrolment.
Population: Publication on effect of administration
of topical magnesium sulphate in the preoperative
period on incidence of POST at 24 h in adult patients
proceeding with surgery under general anaesthesia
was included.
Intervention and comparators: Patients receiving
magnesium sulphate as nebulisation/gargles were
considered the intervention group. Non‑active controls
included normal saline or placebo, whereas active
controls included the use of agents, such as aspirin
and ketamine with a known impact on POST.
Outcome: The primary outcome was the incidence
of POST in 24 h after surgery/extubation. Studies
through inception to July 2018 were included in this
meta‑analysis. Our search included trials published
in both English and non‑English languages. Studies,
which were published as letter to editor with
incomplete data, were excluded.[12]

Data extraction
Comprehensive literature search was performed in
PubMed, Google Scholar, EMBASE, Scopus and the
Cochrane central registers of controlled trial databases
through July 2018. Search terms ‘postoperative sore
throat’, ‘tracheal tube’, ‘magnesium’, ‘randomised
clinical trial’, ‘adult’ and ‘severity’ in various
combinations were used. Parallel‑group, randomised
controlled design showing comparison of topical usage
of magnesium sulphate with either non‑analgesic or
active control; recruiting adult patients undergoing
surgery under general anaesthesia with single lumen
tracheal tube disclosing the incidence and severity of
POST 24 h after surgery/extubation were included in
the meta‑analysis. Search was extended to research
articles published either as full manuscripts or abstracts
of meeting in peer‑reviewed journals. References
of comparable meta‑analysis were also searched
manually for relevant trials. Our search included trials
published in both English and non‑English languages.
Once the abstract was analysed by the searching
reviewer and found appropriate, full text of the article
was further studied.
Two authors (NPS and JKM) independently reviewed
all articles and relevant articles were selected.
Disagreements were resolved through discussion and
in case of any disagreement, PMS was consulted. NPS
and JKM independently extracted data pertaining
to demographic profile of the patients; year and
country of trial, surgery performed; size of tracheal
tube, tracheal cuff pressure, duration of intubation,
interventions used, incidence of POST at various time
intervals, severity of POST, cough and post‑operative
hoarseness. Duplicates obtained from individual
search by different reviewers were identified and were
removed using Endnote (Thompson Reuters, USA).
Data were abstracted into a standardised format entered
into Microsoft Excel 2016 (Microsoft Corporation,
USA). Cross‑references of relevant articles were then
searched to ensure enrolment of all eligible studies.
Assessment of bias and quality of evidence
Risk of bias was assessed using the Cochrane risk of bias
assessment tool.[20] Each randomised trial was assessed
based upon seven domains of potential bias (random
sequence generation, allocation concealment, blinding
of intervention, blinding of outcome assessment,
incomplete outcome data, selective reporting and other
bias). The overall risk of bias of individual studies was
classified as high‑risk if at least two domains were
determined at high‑risk or if there were more than
521
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two domains of unclear risk, moderate risk if at least
two domains were determined at unclear risk, and
low risk if all the domains were determined at low
risk. The grading of recommendations, assessment,
development and evaluation (GRADE) system was
used to assess quality of evidence as high, moderate,
low or very low.[22]

included in the final analysis. The process of screening
and inclusion of RCTs is shown in Figure 1. One trial
by Gupta et al.[12] evaluated the efficacy of nebulised
magnesium sulphate for attenuating POST. Though
authors reported decrease in incidence and severity of
POST till 24 h, actual data were not reported in this
letter to editor.

Outcome measures and statistical analysis
The primary outcome was the incidence of POST
in 24 h after surgery/extubation. Incidence of POST
at 6 h, and severity of POST were the secondary
outcomes analysed. The Mantel–Haenszel (MH) odds
ratio (OR) was calculated for dichotomous outcomes
and standardised mean differences for continuous
outcomes. Data were presented with the corresponding
95% confidence interval (CI). In case data were
presented as median with interquartile range, method
proposed by Wan et al.[23] was used to convert the
values to mean and standard deviation. Statistical
heterogeneity was tested using the I2[24] and Q statistics
Egger’s method[25] was used to assess small study effect
or publication bias. Values of I2 < 40%, 40%–60%,
60%–90% were considered non‑significant, moderate
heterogeneity and high heterogeneity, respectively.[24]

Study characteristics [Table 1]
All the authors monitored the cuff pressure and kept it
below 25–30 cm of H2O throughout the study duration.
Reported tube size was also fairly constant across all
the trials. All the female participant’s tracheas were
intubated with tubes of outer diameter 7–7.5 mm and
8–8.5 mm size was used for male patients. Duration
of tracheal intubation was reported by most of the
authors and it ranged from 51 to 120 min.

Primary analyses were performed pooling both
non‑active and active (analgesic) controls. In case a trial
had more than one arm of intervention, control arm was
considered separately with comparator (magnesium)
for primary analysis.
Comprehensive Meta‑Analysis‑Version 3 (Biostat Inc.,
USA) was used for the statistical analysis. Fixed effect
modelling followed by with random‑effect methods
(after assessing heterogeneity with fixed modelling) was
used for performing the meta‑analysis. Comparative
results were deliberated as pooled mean difference
for continuous variables and Mantel–Haenszel (MH)
OR for dichotomous variables. P < 0.05 was deemed
statistically significant. ‘Fixed effect modelling’ were
used when heterogeneity was found to be lower than
40% otherwise results from random effect modelling
are presented. Egger’s regression test was used to
quantify publication bias and was further judged by
the usage of funnel plot.

RESULTS
Literature search
Initial search yielded 199 titles and abstracts. A total
of 7 trials involving 726 study participants were

Only one trial[16] included participants undergoing
emergency surgery (i.e., acute appendicitis) and the
rest of the trials enrolled elective surgeries, such as
spine, abdominal and orthopaedic procedures.[13‑16,17‑19]
Magnesium was given through topical routes, namely,
nebulisation in four trials,[13,15,18,19] gargles in two
studies[14,16] and lozenges[17] was used in one trial.
Nebulisation dose of magnesium ranged from 225 to
250 mg; 20 mg/kg was given through gargling across the
trials and 100‑mg lozenges were used. Non‑analgesic
controls were normal saline in four trials and placebo
in one trial. The comparator agent with known
analgesic was ketamine in three trials[13,16,19] and
aspirin in one trial.[14] Information on characteristics
of patient, anaesthetic techniques, surgical procedures
and number of interventions are listed in Table 1.
Trial by Rajan et al. and Jain et al. compared three
groups (two active and one control) as the values of
individual groups were reported separately; we were
able to obtain two comparisons for pooled results
from both these studies. These comparison arms are
labelled as (1) and (2) for better reader comprehension
and to avoid group identification confusion.
In one trial, the study participants were in prone
position for surgery;[18] in three trials, surgery was
undertaken with patients in supine position[13,16,19] and
the remaining three studies did not mention the surgical
position.[14,15,17] Only one trial used succinylcholine as
muscle relaxant for intubation,[16] whereas the rest of the
researchers used non‑depolarizing muscle relaxants.
The study participant’s mean age was 37.14 ± 10.66
in control group and 36.86 ± 10.22 in comparator
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Figure 1: Flowchart showing selection of RCT for meta‑analysis

group. One group of researchers enrolled only female
participants,[19] one group did not report patient’s
gender,[13] but others enrolled subjects of either sex.[14‑18]
Control and treatment groups in the reported trials had
comparable distribution of genders. Six trials included
patients with ASA physical status 1–2,[14‑19] whereas
only one trial included patients with ASA physical
status 1–3.[19]
Study quality assessment
Figure 2 shows the methodological qualities of
selected studies. Methods of allocation generation
were described in four trials,[13,14,17,19] and two
studies provided the detailed methods of allocation
concealment.[17‑19] Four studies provided detailed
information regarding the blinding of patients as well
as assessors.[13,14,17,19]
Primary outcome
Data of sore throat 24 h postoperatively were
available in 7 trials that included 363 patients in

control and 363 patients in the comparator group.
Incidence of POST was significantly lower in
comparator group (26/363) in comparison to control
group (89/363); P = 0.00, RR 0.22 (95% CI = 0.12–0.39
I2 = 0%) [Figure 3]. All these seven trials reporting the
primary outcome were also further sub‑grouped based
upon the use of non‑active control. On subgroup
analysis, incidence of POST was significantly lower
in the comparator group (12/220) as compared to the
non‑active control group (57/220); P = 0.00. RR 95%
CI 0.18 (0.09–0.36). Four trials used known analgesic
agents as comparator. The active comparator was
ketamine in three trials and aspirin in one trial. When
compared with ketamine or aspirin, there was no
statistically significant difference in the incidence of
sore throat with use of magnesium.
Topical magnesium reduced the severity of POST
by nearly 78% as compared to the control group at
24 h after surgery. The number needed to treat for
reduction of one episode of sore throat with the use
523
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Table 1: Characteristics of studies included
Author/
country
Borazan
(2012)
Turkey[17]

Sample
Age Duration of surgery/ Post‑op
Intervention
size (F%)
anaesthesia (min) analgesia
70 (30) 18‑50
84±12
Tramadol 1. Magnesium‑Diasporal lozenge
containing 100 mg magnesium
86±9
2. Placebo lozenges
Chattopadhya 56 (25) 18‑50
50.4±6.9
PCM
1. Gargling with 20 mg/kg magnesium
(2016)
sulfate solution dissolved into 20 mL of
53.3±7.3
India[14]
5% dextrose solution
2. Gargling with 325 mg tablet dissolved
into 20 mL of 5% dextrose solution
Jain (2017)
150 (100) 20‑50
<120
PCM &
1. Nebulisation with 3 ml of 225 mg
India[19]
Tramadol isotonic magnesium sulfate
2. Nebulisation with 3 ml solution
containing 50 mg ketamine
3. Nebulisation with 3 ml normal saline
Rajan (2017)
60 (NR) 18‑80
comparable
Epidural
1. Nebulisation with 5 ml solution
India[13]
containing 250 mg magnesium
2. Nebulisation with 5 ml solution
containing 500 mg magnesium
3. Nebulisation with 5 ml solution
containing 50 mg ketamine
4. Nebulisation with 5 ml solution
containing normal saline
Sharma
140 (30) 25‑50
127.8±9.7
Diclofenac 1. Nebulisation with magnesium sulfate
(2017)
225 mg 1 ml with 4.0 ml of normal saline
131.4±8.2
India[18]
2. Nebulisation with 5 ml normal saline
Teymourian
100 (46) 25‑75
52.5±23.4
NM
1. Gargling with 20 mg/kg magnesium
(2015) Iran[16]
sulfate in 30 mL 20% dextrose water
55.8±21.2
2. Gargling with 0.5 mg/kg ketamine in
30 mL 20% dextrose water
Yadav (2016) 100 (47) 18‑60
approx. 120
NM
1. Nebulisation with 3 ml of 225 mg
India[15]
isotonic magnesium sulfate
2. Nebulisation with 3 ml of normal saline

Tracheal Cuff pressure
tube (F)
(cm H2O)
8.5 (7.5)
20‑22

8‑9 (7‑8)

18‑20

(7‑7.5)

20

8‑8.5
(7‑7.5)

20‑25

8‑8.5
(7‑7.5)

10‑20

NM

20‑30

8 (7)

20

NM – Not mentioned, PCM – Paracetamol

of magnesium was 5.76. This comparison had ‘zero’
overall heterogeneity.

excluding ketamine arm of the trial, the heterogeneity
dropped to 49.14%.

Secondary outcomes
Incidence of early sore throat
Sore throat at 6 h: The incidence of sore throat
at 6 h was available in all the seven trials.
Incidence of sore throat was significantly lower
in the comparator group 66/363 in comparison
to the control group 141/363; P < 0.001, RR
0.22 (95%CI = 0.14–0.34 I2 = 68.31%, random
effects) [Figure 4]. This amounted to a reduction of
78% in the incidence of sore throat in comparison
to the control group. Number needed to treat (NNT)
for prevention of single episode of early sore throat
with the use of magnesium was 4.84. Grade quality
of evidence was judged to be high.

Severity of sore throat
Six trials provided information on severity of sore
throat. None of the patients developed severe sore
throat in any of the studies.

We performed a sensitivity analysis using ‘single
study removal method’ to explore for the high
heterogeneity for this variable. The study by Rajan
et al. contributed highly to the heterogeneity and on

Mild severity: The incidence of mild sore throat was
disclosed in six trials. The overall incidence of mild
sore throat was 12/248 in the magnesium group
compared to 28/248 in the control group. The MH
OR for mild sore throat with the usage of magnesium
was 0.43 (95%CI being 0.21–0.87) [P = 0.02,
I2 = 0%] [Figure 5]. This amounted to nearly 57%
reduction in incidence of mild sore throat with the use
of magnesium with an NNT of 15.50. Grade quality of
evidence was judged to be moderate.
Moderate sore throat: This variable was reported by
5 trials that included 213 patients each in magnesium
and control groups. Incidence of moderate sore throat
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was 0.04% and 9.38% with magnesium and control,
respectively. The MH OR for sore throat with usage of
magnesium as compared to control was 0.15 (95%CI
being 0.05–0.5), [P = 0.00, I2 = 0%] [Figure 6].

Magnesium led to reduction of moderate degree of
sore throat by around 85% over control group with an
NNT of 11.21.
Comparison with ketamine: Magnesium usage was found
to be comparable to topical ketamine, reported in 3 trials
with 230 patients in preventing sore throat at 24 h, MH
OR was 0.53 (95%CI being 0.14–1.97) [P = 0.34].
Only four studies commented on incidence of
hoarseness and cough at 24 h. No cough or hoarseness
was found at 24 h in three studies and in one trial
only one patient had hoarseness at 24 h.[14] Three trials
reported the information on adverse events associated
with study drug.
Publication bias
Both funnel plot and Egger’s regression test were
used to evaluate for the publication bias in 24‑h
incidence of sore throat (primary variable). There was
a symmetrical distribution of trials on Funnel plot.
Egger’s test demonstrated an X‑axis intercept at 0.096
with P values of 0.916 (two‑tailed) [Figure 7]. Both
these indicated that the publication bias was unlikely.

DISCUSSION
Figure 2: Risk of bias summary

We conducted this meta‑analysis to assess the efficacy
of topical magnesium in preventing POST in adult

Figure 3: Forest plot showing comparison of magnesium with control in 24 h
525
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Figure 4: Forest plot showing comparison of magnesium with control at 6 h

Figure 5: Forest plot depicting incidence of mild sore throat for magnesium and control at 24 h

patients undergoing surgery with general anaesthesia
and oral intubation. We found that magnesium is
an effective agent to reduce the incidence of POST.
Prophylactic use of magnesium against POST is
also associated with a reduction in severity of this
undesirable post‑operative complication.

POST is a minor but distressing post‑operative
complication. Only a limited number of research
articles on airway complications have studied
POST, even though it hampers the patient’s recovery
and potential increased health care cost.[26‑28] In
this systematic review, use of magnesium was
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Figure 6: Forest plot showing incidence of moderate sore throat for magnesium and control at 24 h

POST‑related outcomes because of the lack of
information in the trials included.

Figure 7: Funnel plot of standard error

associated with significant reduction in incidence
of sore throat during the first 24 h after surgery
in comparison with placebo group without any
significant adverse effect documented. The number
needed to prevent POST when using magnesium
was 5.76 indicating a large prophylactic effect.
Grade quality of evidence for incidence of POST
reduction with use of magnesium was high. Use of
this drug reduced the severity of POST by nearly
78%. Among the deleterious outcomes secondary
to POST in patients, the most important are
delayed discharge, discomfort and even dangerous
sympathetic response. However, we were not
able to measure the effect of magnesium on these

The trigger of POST is usually pharyngolaryngeal
mucosal inflammation secondary to localised trauma
inflicted by cuff of tracheal tube. Therefore, a high
number of anti‑inflammatory agents have been
proposed to be effective in reducing POST.[29‑32] Tanaka
et al., in their meta‑analysis reported positive results
with lignocaine that were dependent on study quality;
drug concentration; route of administration and
management of cuff pressure during anaesthesia.[33]
Administration of ketamine gargle prior to induction of
general anaesthesia with airway instrumentation was
found to improve patient satisfaction by decreasing
patient discomfort and the need for adjunct pain
therapy in a meta‑analysis conducted by Mayhood
et al.[34] Corticosteroids applied to tracheal tubes were
superior both to non‑analgesic controls and lignocaine,
in preventing POST in a meta‑analysis conducted by
Kuriyama et al.[35] Same group of authors conducted
another meta‑analysis to assess the efficacy and safety
of topical application of benzydamine to prevent POST
in adults undergoing elective surgery under general
anaesthesia.[36] Authors found that benzydamine was
also associated with a reduced incidence of POST
when compared with lignocaine. However, the effects
of benzydamine hydrochloride on the incidence of
POST have only been compared in small trials.
527
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Consolidated standards of reporting trials (CONSORT)
statement requires trial investigators to report on
harms associated with interventions.[37] Though all
seven trials were published after publication of this
statement; four trials did not report adverse effects
of their intervention.[14,16,18,19] Our analysis of the
limited evidence available suggests that topical use of
magnesium is not associated with greater incidence of
adverse events. As for the potential side effects of topical
magnesium like gastric irritation, diarrhoea or nausea
were noted in one trial[17] and author did not observe
any of these side effects. Other three studies[14,15,18] did
not define the side effects they had noticed. However,
they reported absence of any adverse effects.
Magnesium was administered as gargles, lozenges or
nebulisation 15–30 min before surgery in preoperative
area. Only one study defined the size of droplets
produced by the nebuliser. Jain et al. used nebuliser
that produced droplets of size 5–8 microns resulting
in only 37%–60% of the drug getting deposited in
oropharynx. Nebulisation ensures that the drug
is equally and effectively distributed all over the
pharynx and up to the beginning of the respiratory
tract. In addition, nebulisation prevents the user
variability associated with gargling and confounded
the issue of taste of the medications.[19] Lozenges
used allow immediate release of the drug, which
adheres to the pharyngeal wall and decreases the
oedema. Further magnesium thus released has local
analgesic and anti‑inflammatory effects, especially
in the presence of alkaline pH, in which magnesium
is highly concentrated in inflamed tissue and has
minimal systemic absorption. This prolongs the action
and decreases possibility of side effects.[17]
One of the strengths of our meta‑analysis was that
greater proportion of enrolled randomised controlled
trials used a similar route of administration and dose
of magnesium. Furthermore, our analysis showed
no heterogeneity. In addition to incidence of POST,
we were also able to define the effect of magnesium
on severity of POST as five out of seven trials had
data pertaining to severity also. Third, we used
the Cochrane methodology when performing this
systematic review. Quality of evidence was assessed
using the GRADE criteria. We further confirmed the
robustness of our findings using sub‑group sensitivity
and trial sequential analyses.
There are few limitations of this meta‑analysis. First,
the minimum dose of magnesium required for optimal

effect could not be defined as most of the studies used
similar doses. Second, only the effect of magnesium as
compared to placebo could be studied because of the
limited number of studies comparing magnesium with
active control. Though our results suggest that topical
magnesium is associated with reduced sore throat,
our study was not able to prove whether it is better
than or equivalent to other agents like lignocaine,
corticosteroids or ketamine. We could not perform a
meta‑regression analysis because of limited number of
studies. We could not adjust for variables like higher
cuff pressure and larger tracheal tubes size, which are
known risk factors for POST. Additionally, as only four
trials collected the data on adverse events associated
with magnesium, we could not assess the safety of the
drug. Publication bias is present in some outcomes
despite our comprehensive search

CONCLUSION
Prophylactic topical magnesium, before the induction
of general anaesthesia, seems to be an effective measure
to decrease the incidence of POST. We encourage
the use of this agent in clinical practice and suggest
further studies that assess the impact of magnesium
on patient’s recovery and the cost‑effectiveness of this
strategy.
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